JDD Corner

JDD Issue Highlights | January 2022 | Aesthetic Treatments
Aesthetic TreatmentsThe Journal of Drugs in Dermatology kicks off 2022 with an outstanding line up of editorials, original articles, and case reports focusing on aesthetic treatments. Straight from the Editor’s desk, we share this month’s issue highlights: Authors establish that the test device is non-inferior to the comparator in Safety and Effectiveness of a Novel Hyaluronic Acid Gel for Lip Augmentation. …
Aesthetic Treatments
Botulinum Toxin in the Long-Term Treatment of Refractory Raynaud’s Phenomenon
Refractory Raynaud’s PhenomenonRaynaud’s phenomenon is an exaggerated physiological response of blood vessels in the distal extremities to emotional stress and cold. It can be idiopathic or secondary to a connective tissue disorder, such as scleroderma or systemic lupus erythematosus. Treatment for Raynaud’s phenomenon consists primarily of lifestyle modifications; if unsuccessful, pharmacotherapy with dihydropyridine calci …
Refractory Raynaud’s Phenomenon
Infraorbital Occlusion Treated with High-Dose Pulsed Hyaluronidase Protocol
Infraorbital OcclusionFacial fillers are an increasingly popular cosmetic procedure used for facial rejuvenation. Regardless of the experience and skill level of the injector, fillers can inadvertently occlude vessels leading to blockage of cutaneous blood supply, ischemic skin necrosis and rarely cerebrovascular strokes and blindness. Injectors should recognize early signs of occlusion and be prepared with knowledge a …
Infraorbital Occlusion
JDD Issue Highlights | December 2021
JDDAs 2021 draws to a close, the  Journal of Drugs in Dermatology ends the year on a high note! Featuring a strong line up of editorials, original articles, and case reports, the December issue of the JDD includes topics ranging from new treatments for hyperpigmentation, tumescent anesthesia, HS, cosmeceuticals, lower extremity reconstruction, laser hair and identity in transgender men, and everyt …
JDD
Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar PustulosisPalmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
Palmoplantar Pustulosis